课题基金 / 基金详情

LC-MS/MS for Biomedical Research

LC-MS/MS for Biomedical Research
用于生物医学研究的 LC-MS/MS
批准号:
6712011
负责人:
WILLIAM BRYSON CAMPBELL
金额:
$24.56万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2005-03-31

项目摘要

项目成果

WILLIAM BRYSON CAMPBELL的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):请提供资金购买一台液体色谱仪-三重四极杆质谱仪(LC-TQ MS)Waters Quattro Micro API串列四极杆系统),供威斯康星医学院的研究人员作为共享仪器使用。该学院有950名教员和NIH资金,但没有共享LC-MS/MS仪器。这一仪器对未来的研究至关重要。在过去的11年里,药理学和毒理学系的质谱学共享设施为学院的教职员工提供了质谱学专业知识和仪器。该机制制定了处理来自多个用户的样品和处理具有不同化学特性的样品的协议。它拥有惠普气相色谱-单四极质谱计(引擎)和安捷伦液相色谱-单四极质谱计(LC-MSD)。LC-MSD目前被许多研究人员广泛用于脂类、类固醇激素、多肽和蛋白质的分析。这些不同的需求产生了对LC-MS分析的日益增长的需求。因此,我们请求购买LC-TQ MS,因为它的MS/MS功能将克服当前仪器的许多限制。这种MS/MS能力将有助于未知化合物的鉴定。这一功能目前由GC-MS执行,这需要样品衍生化并与GC条件兼容。由于可以选择不同m/z的子离子进行测量,LC-TQ MS还将有助于具有相同m/z的分析物的测量。这将增加对复杂样品中某些峰的分析的置信度。由于LC-MSD需要完全拆分具有相同m/z的多种化合物,因此它还将导致运行时间缩短。这项赠款的15个主要用户的需求分为四类:(1)二十烷类化合物的鉴定和测量,(2)脂质过氧化产物、异前列腺素和氧基脂的测量,(3)成瘾药物及其代谢物的分析,以及(4)其他应用。大约75%-80%的仪器时间将提供给这些参与者,其余的时间将提供给学院的其他研究人员。
英文摘要
DESCRIPTION (provided by applicant): Funds are requested to purchase a liquid chromatograph - triple quadrupole - mass spectrometer (LC-TQ MS) Waters Quattro micro API Tandem Quadrupole System) for use as a shared instrument by researchers of the Medical College of Wisconsin. The College has 950 faculty and NIH funding but has no shared LC-MS/MS instrumentation. This instrument is critical for future research. During the past 11 years, the Mass Spectrometry Shared Facility of the Department of Pharmacology and Toxicology has provided mass spectrometry expertise and instrumentation to the faculty of the College. The Facility has established protocols for handling samples from multiple users and dealing with samples with different chemical characteristics. It has a Hewlett - Packard gas chromatograph - single quadrupole mass spectrometer (Engine) and an Agilent liquid chromatograph - single quadrupole mass spectrometer (LC-MSD). The LC-MSD is currently widely used by a number of investigators for analysis of lipids, steroid hormones, peptides and proteins. These varied needs have created an increasing demand for LC-MS analysis. Therefore, we request the purchase of a LC-TQ MS because of its MS/MS capabilities that will overcome many of the limitations of the current instrument. This MS/MS capability will facilitate the identification of unknown compounds. This function is currently performed by GC-MS, which requires sample derivatization and compatibility with GC conditions. The LC-TQ MS will also facilitate the measurement of analytes with the same m/z since daughter ions of different m/z may be selected for measurement. This will result in increase in confidence in analysis of certain peaks in complex samples. It will also result in shorter run time since the LC-MSD needs a complete resolution of multiple compounds with same m/z. The needs of the 15 principal users of this grant fall into four categories: (1) identification and measurement of eicosanoids, (2) measurement of lipid peroxidation products, isoprostanes and oxylipids, (3) analysis of addictive drugs and their metabolites, and (4) miscellaneous applications. About 75-80% of instrument time will be available to these participants and the remaining time will be available to other investigators at the College.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
12/15-lipoxygenase: Immune cell mediator linking innate immunity to hypertension
  • 批准号:
    10318163
  • 项目类别:
  • 资助金额:
    $52.58万
  • 财政年份:
    2019
  • 负责人:
    WILLIAM BRYSON CAMPBELL
  • 依托单位:
12/15-lipoxygenase: Immune cell mediator linking innate immunity to hypertension
  • 批准号:
    9884096
  • 项目类别:
  • 资助金额:
    $52.58万
  • 财政年份:
    2019
  • 负责人:
    WILLIAM BRYSON CAMPBELL
  • 依托单位:
12/15-lipoxygenase: Immune cell mediator linking innate immunity to hypertension
  • 批准号:
    10532358
  • 项目类别:
  • 资助金额:
    $52.58万
  • 财政年份:
    2019
  • 负责人:
    WILLIAM BRYSON CAMPBELL
  • 依托单位:
Substance P: A central mediator of cardiac fibrosis and diastolic dysfunction
  • 批准号:
    9308567
  • 项目类别:
  • 资助金额:
    $35.48万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM BRYSON CAMPBELL
  • 依托单位:
海外基金